- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
SUPPORT PHILSTAR
About Us |
Contact Us |
Advertise |
Privacy Policy |
Member Agreement |
Copyright Notice
Copyright © 2024. Philstar Global Corp. All Rights Reserved
X
+ Follow BREAST CANCER INTERNATIONAL RESEARCH GROUP Tag
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 551569 [Title] => Greater chances of cure for patients with breast cancer [Summary] =>Roche announced recently its new long-term follow up-data from two large pivotal studies evaluating adjuvant trastuzumab in HER2-positive early- stage breast cancer presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).
[DatePublished] => 2010-02-22 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) [1] => Array ( [ArticleID] => 294479 [Title] => Beating the odds in breast cancer [Summary] => First, the bad news: The Philippines has the highest incidence of breast cancer in Southeast Asia. An estimated 14,000 new cases of breast cancer are expected to occur this year, according to a report by the Philippine Cancer Society.
Breast cancer is the leading cause of death among Filipino women, and about 6,000 of them are estimated to die from the disease this year.
The good news is that in the last few years there have been exciting developments in the treatment of breast cancer, the most common type of malignancy, next to lung cancer.
[DatePublished] => 2005-09-01 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [2] => Array ( [ArticleID] => 246270 [Title] => Breast cancer drug boosts survival [Summary] => At least 1,500 lives could be saved every year if a drug used to treat terminal breast cancer cases is given early in the disease.
The Breast Cancer International Research Group (BCIRG) said docetaxel (distributed by Aventis Pharma Inc.) significantly improved the survival rate of women with early-stage breast cancer and reduced their risk of a relapse compared with a standard treatment. This implies that docetaxel is a potential life-saver and should not only be used in terminally ill patients to buy extra time.
[DatePublished] => 2004-04-15 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
BREAST CANCER INTERNATIONAL RESEARCH GROUP
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 551569 [Title] => Greater chances of cure for patients with breast cancer [Summary] =>Roche announced recently its new long-term follow up-data from two large pivotal studies evaluating adjuvant trastuzumab in HER2-positive early- stage breast cancer presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).
[DatePublished] => 2010-02-22 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Freeman Cebu Lifestyle [SectionUrl] => cebu-lifestyle [URL] => ) [1] => Array ( [ArticleID] => 294479 [Title] => Beating the odds in breast cancer [Summary] => First, the bad news: The Philippines has the highest incidence of breast cancer in Southeast Asia. An estimated 14,000 new cases of breast cancer are expected to occur this year, according to a report by the Philippine Cancer Society.
Breast cancer is the leading cause of death among Filipino women, and about 6,000 of them are estimated to die from the disease this year.
The good news is that in the last few years there have been exciting developments in the treatment of breast cancer, the most common type of malignancy, next to lung cancer.
[DatePublished] => 2005-09-01 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [2] => Array ( [ArticleID] => 246270 [Title] => Breast cancer drug boosts survival [Summary] => At least 1,500 lives could be saved every year if a drug used to treat terminal breast cancer cases is given early in the disease.
The Breast Cancer International Research Group (BCIRG) said docetaxel (distributed by Aventis Pharma Inc.) significantly improved the survival rate of women with early-stage breast cancer and reduced their risk of a relapse compared with a standard treatment. This implies that docetaxel is a potential life-saver and should not only be used in terminally ill patients to buy extra time.
[DatePublished] => 2004-04-15 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
February 22, 2010 - 12:00am
September 1, 2005 - 12:00am
April 15, 2004 - 12:00am
Recommended
Football and other sports will soon get a new hub at the Villar City Stadium that will rise inside the Golden MV’s Villar City in Bacoor, Cavite.
23 hours ago
Olympic pole vaulter EJ Obiena has opened up about his mother, Jeanette, and how they healed from that sports controversy that “strained” their relationship.
23 hours ago
Football and other sports will soon get a new hub at the Villar City Stadium that will rise inside the Golden MV's Villar City in Bacoor, Cavite.
1 day ago
Showing she can compete against the top pros, 17-year-old Filipina amateur Rianne Malixi fired a strong three-under 69 opening card that put her just four off the lead in the Hana Financial Group Championship in Incheon, Korea.
1 day ago
St. Benilde big man Allen Liwag promised a better version of himself entering NCAA Season 100.
1 day ago
Lotto Sep 29, 2024
EZ2 - 14 20
SUERTRES - 7 5 1
6/49 Lotto - 21 39 15 45 26 3
P15,840,000.00
6/58 Ultra Lotto - 20 40 26 46 38 1
P211,813,673.00
Forex
February 12, 2018
- 12:00 am
- 12:00 am
1$ : P51.66